Clinical Trials Logo
  1. Home
  2. Invasive Pulmonary Aspergillosis
  3. NCT03672292

Study to Evaluate the Safety and Efficacy of the Coadministration of Ibrexafungerp (SCY-078) With Voriconazole in Patients With Invasive Pulmonary Aspergillosis — SCYNERGIA  

Invasive Pulmonary Aspergillosis Clinical Trial

Official title:
A Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of the Coadministration of SCY-078 With Voriconazole in Patients With Invasive Pulmonary Aspergillosis

Clinical Trial Summary

Study to evaluate the safety and efficacy of coadminstration of SCY-078 with a mold-active azole (voriconazole) compared to voriconazole in patients with invasive pulmonary aspergillosis.

Clinical Trial Description

This is a multicenter, randomized, double-blind, two-arm study to evaluate the safety, tolerability, efficacy and PK of the coadministration of SCY-078 plus voriconazole compared to those of voriconazole in male and female subjects 18 years of age and older with a probable or proven invasive pulmonary aspergillosis. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03672292
Study type Interventional
Source Scynexis, Inc.
Contact
Status Completed
Phase Phase 2
Start date January 22, 2019
Completion date March 27, 2023
View Details
See also
  Status Clinical Trial Phase
Completed NCT01782131 - A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis (MK-5592-069) Phase 3
Recruiting NCT05138666 - Non-invasive Tools to Diagnose Invasive Aspergillosis Infections in ICU Patients With COVID-19 and Other Conditions. N/A
Not yet recruiting NCT02234739 - Voriconazole for IPA in Chinese Patients With COPD Phase 4
Completed NCT01615809 - Nebulized Amphotericin B Lipid Complex in Invasive Pulmonary Aspergillosis in Paediatric Patients With Acute Leukaemia Phase 2
Completed NCT04267497 - Nebulised Liposomal Amphotericin for Invasive Pulmonary Aspergillosis (NAIFI01 Study) Phase 1
Recruiting NCT05860387 - Early Diagnosis of Invasive Lung Aspergillosis
Withdrawn NCT01188759 - Voriconazole And Anidulafungin Combination For Invasive Aspergillosis In Pediatric Subjects Phase 3
Completed NCT00923832 - Early Molecular Detection for the Improved Diagnosis of Invasive Pulmonary Aspergillosis and Invasive Pulmonary Zygomycosis N/A
Recruiting NCT05982912 - VOC in Breath Samples for the Diagnosis of IPA
Not yet recruiting NCT02100761 - CYP 2C19 Polymorphism and Voriconazole Trough Concentration in Chinese Adult Patients N/A
Recruiting NCT00986713 - Value of Amphotericin B Inhalation for Prophylaxis of Invasive Pulmonary Aspergillosis After Renal Transplantation Phase 4
Recruiting NCT05569824 - LFD of Aspergillus Antigen in Paediatrics
Not yet recruiting NCT04848831 - Diagnosis of Invasive Pulmonary Aspergillosis, Specific Testing in Bronchial Secretions Versus Bronchoalveolar Fluid
Completed NCT04077697 - Clinical and Prognostic Comparisons Between Invasive Pulmonary Aspergillosis With or Without Invasive Tracheobronchitis During Severe Influenza: a Retrospective Multicenter Cohort Study.
Recruiting NCT01499433 - Efficacy and Safety of Caspofungin for Invasive Pulmonary Aspergillosis Underlying Chronic Obstructive Pulmonary Disease Phase 4
Completed NCT01247142 - Evaluation of Exhaled Breath Condensate in the Diagnosis of Invasive Pulmonary Aspergillosis N/A
Completed NCT00501098 - Prophylaxis of Fungal Invasive Infections in Leukemia Phase 2
Recruiting NCT03748069 - Influenza Associated Aspergillosis In-depth Investigation
Completed NCT02058316 - Bronchoalveolar Lavage Lateral-Flow Device Test for Invasive Pulmonary Aspergillosis: a Multicenter Study
Terminated NCT03327727 - VL-2397 Compared to Standard First-Line Treatment for Invasive Aspergillosis (IA) in Adults Phase 2